治療に抵抗する双極性うつ病におけるケタミンへの反応の欠如
Zofia Kachlik1, Wiesław Jerzy Cubała1, Michał Walaszek1
1Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, Gdańsk, Poland.
Neuropsychopharmacology reports
|August 29, 2025
まとめ
治療抵抗性双極性うつ病 (TRBD) のケタミンの非反応は,より多くの精神疾患とベンゾジアゼピンの使用に関連していました. これらの要因を理解することで ケタミン抗うつ薬の治療を最適化できます
科学分野:
- 精神科
- 薬理学について
背景:
- ケタミンは治療に抵抗する双極性うつ病 (TRBD) の迅速作用抗うつ剤です.
- 多くの患者はケタミン治療に有意な反応を得られない.
- この研究では,TRBD患者におけるケタミン不応答に関連する要因を調査した.
研究 の 目的:
- ケタミンの不反応とTRBDの反応を区別する特徴を探求する.
- 治療結果と関連したベースラインの特徴を特定する.
主な方法:
- 自然主義的な研究のポストホック分析.
- TRBD患者は4週間のケタミン療法 (IVまたは経口) を受けました.
- モンゴメリー- アスバーグのうつ病評価尺度で評価された反応; 応答者と非応答者の間のベースライン特徴の比較.
主要な成果:
- 患者の40% (14/35) は反応しなかった.
- 非応答者では精神疾患の併発が多く (中位は2対1),併発率も高かった (78. 6%対33. 3%).
- 前回のベンゾジアゼピンの使用は,非応答者においてより多く観察された (64. 3% 対 23. 8%).
結論:
- ケタミンはTRBDにおける短期的な安全性と耐受性を示しています.
- ベンゾジアゼピンの使用前の併発症の負担が高く,ケタミンの非反応と関連している.
- これらの発見は,TRBDのパーソナライズされた治療戦略を参考にすることができます.
関連する概念動画
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Electroconvulsive Therapy
182
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
182
Mania and Antimanic Drugs: Overview
318
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
318
Antidepressant Drugs: MAOIs and Other Agents
340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
293
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
293
Drug Therapy
96
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
96


